HuMab-7D8, a monoclonal antibody directed against the membrane-proximal small loop epitope of CD20 can effectively eliminate CD20 low expressing tumor cells that resist rituximab-mediated lysis.

T. van Meerten, H. Rozemuller, S. Hol, P. Moerer, M.C. Zwart, A. Hagenbeek, W.J.M. Mackus, P.W.H.I. Parren, J.G.J. van de Winkel, S.B. Ebeling, A.C.M. Martens

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2063-2071
Number of pages9
JournalHaematologica
Volume95
Issue number12
Publication statusPublished - 2010

Cite this